Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience
Clinical Obesity · 2025-02 · 15 (1)
DOI: 10.1111/cob.12705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Obesity, online erschienen am 22.09.2024. Verfasst von Bernarda Patiño Araujo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clínica Bariátrica Dr. Napoleón Salgado, Quito, Ecuador. Hauptthemen laut MEDLINE: Gastric Balloon, Body Composition, Weight Loss. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
People with excess weight and obesity compose 64.5% of the Ecuadorian population. The Allurion Intragastric Balloon (IGB) is a noninvasive weight loss alternative for patients ineligible for other bariatric procedures. The impact of the procedure on weight loss and body composition, along with insertion complications and secondary effects were investigated. This is a single‐centre retrospective study of patients who underwent Allurion IGB insertion from July 2020 to March 2021. This study followed 167 patients for 12 months after EIGB insertion. Our sample had a mean initial weight of 83.6 ± 13.8 kg and initial body mass index of 31.3 ± 3.6 kg/m 2 . Percentage total weight loss was 4.65% ± 0.56%, 8.5% ± 4%, 12.29% ± 4.65%, 15.68% ± 5.22%, 17.14% ± 6.05%, and 14.68% ± 18.02% for months 1, 2, 3, 4, 6 and 12, respectively. In the fourth month, 92 patients (56.4%) had lost ≥50% excess body weight; at month 6, 104 patients (67.5%) achieved this goal. Regarding body composition, body fat percentage started at 38.99% ± 7.92%, and at month 6 was 35.67% ± 6.84%, this was the only significance in the statistical analysis.This study aligns with the literature's safety and efficacy results for the Allurion IGB while illustrating the need for further research regarding weight behaviour after its expulsion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clínica Bariátrica Dr. Napoleón Salgado, Quito, Ecuador.
- Cochrane Central Executive Team, Cochrane Geographic Groups and Fields, Oakham, UK.
ORCID-Profile: Bernarda Patiño Araujo, Karla Elizabeth Duque Jácome, María Emilia Salgado Báez, Gabriel Villavicencio Logroño, Napoleón Salgado Macías
Zitieren
APA
Patiño Araujo, B., Duque Jácome, K. E., Salgado Báez, M. E., Villavicencio Logroño, G., & Salgado Macías, N. (2025). Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience. Clinical Obesity, 15(1). https://doi.org/10.1111/cob.12705
Vancouver
Patiño Araujo B, Duque Jácome KE, Salgado Báez ME, Villavicencio Logroño G, Salgado Macías N. Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience. Clinical Obesity. 2025;15(1). doi:10.1111/cob.12705
BibTeX
@article{PatioAraujo2025,
author = {Patiño Araujo, Bernarda and Duque Jácome, Karla Elizabeth and Salgado Báez, María Emilia and Villavicencio Logroño, Gabriel and Salgado Macías, Napoleón},
title = {Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience},
journal = {Clinical Obesity},
year = {2025},
volume = {15},
number = {1},
doi = {10.1111/cob.12705}
}
EUVIMED